Breaking Mining Stock News: New Destiny Mining (TSXV: $NED.V) Drilling Hole 7 Intersects Porphyry Dikes and Copper Mineralization at Treasure Mountain Silver Project, Hope BC; @NEDminingcorp

Breaking Mining Stock News: New Destiny Mining (TSXV: $NED.V) Drilling Hole 7 Intersects Porphyry Dikes and Copper Mineralization at Treasure Mountain Silver Project, Hope BC; @NEDminingcorp

 

VANCOUVER, British Columbia - August 27, 2024 (Investorideas.com Newswire) New Destiny Mining Corp. (TSXV: NED), (the "Company" or "NED") provides a further update on its 2024 exploration program at the Treasure Mountain project, near Princeton, BC.

 

Drilling continues at the Treasure Mountain property with seven holes completed so far for a total of 1328.5 meters cored. All the holes have been drilled in the Railroad area of copper-silver mineralization.

 

Hole 7 (TMN24-07) targeted a soil copper anomaly (values to 112 ppm copper) located southeast of the Railroad adits (Figure 1) that could possibly be an extension of the Railroad copper-silver mineralized zone. Fracture controlled malachite copper mineralization occurs in a road cut near the collar position of this hole.

 

The hole was drilled to a depth of 268.5 meters and intersected multiple intervals of altered felsic porphyry amounting to 21.9 meters or 8% of the core. Alteration consists of pervasive pale green sericite and quartz with pyrite. A quartz vein mineralized with chalcopyrite (copper) and tetrahedrite (silver and antimony-bearing mineral) occurs within one of the altered porphyry intervals at 43.7 meters depth (Figure 2). Analysis using a portable XRF indicates the presence of significant copper (0.34%) and antimony (0.16%). Chalcopyrite mineralization was also observed in the host Zoa Intrusive Complex at 79.13 meters. Near the bottom of the hole, a mineralized altered porphyry dike was intersected, containing disseminated and fracture-controlled pyrite and possible fine-grained chalcopyrite (Figure 3).

 

The results indicate the soil anomaly is underlain and possibly sourced by copper-silver mineralization related to altered felsic porphyry dikes. The association between altered porphyry and mineralization appears to be characteristic of the Railroad copper-silver area.

 

Paid news dissemination on behalf of New Destiny Mining.

 

Read this news, featuring NED in full at https://www.investorideas.com/news/2024/08271NED-Hole-7-Porphyry-Copper.asp

 

 

 

Figure 2. Photo of core from hole TMN24-07 showing quartz vein mineralized with chalcopyrite and tetrahedrite at 43.7 meters depth

 

Figure 1. Color grid map of Cu ppm from Railroad 2015 soil survey, showing location of Hole TMN24-06 and planned location of hole 7

 

Figure 3. Photo of core from hole TMN24-07 showing altered porphyry from 253.3 to 259.2 meters (upper) mineralized with fracture-controlled pyrite (lower, close-up)

The Treasure Mountain property covers 10,819 hectares and is located 38 km west of the Copper Mountain mine at Princeton in southern BC. Targets on the property include critical minerals in porphyry copper-moly deposits, and gold-quartz vein and polymetallic silver-rich vein deposits.

Map showing Treasure Mountain property and targets for 2024

Portable XRF (X-Ray Fluorescence) readings are semi-quantitative measurements and are used as guideline to augment the understanding of the mineralization observed. These measurements are not intended to be representative of the geochemical composition of the material measured. XRF readings are carried out using a handheld device and could be influenced by external factors. Calibrations of the equipment in the field do not always allow comparison with results of certified reference materials.

 

Readers are cautioned that historical records referred to in this News Release have been examined but not verified by a Qualified Person. Further work is required to verify that historical records referred to in this News Release are accurate.

 

Dr. Mathew Ball, P.Geo., a Qualified Person as defined by NI 43-101 and consultant to the Company, approved the technical information contained in this News Release.

 

ON BEHALF OF THE BOARD OF DIRECTORS

"Al Beaton"

Director

604-488-3900

 

Investor Relations:
Lubica Parilakova
ir@NewDestinyMining.com

Forward Looking Information

This news release includes certain statements that constitute "forward-looking information" within the meaning of applicable securities law, including without limitation, the Company's information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Such statements include statements regarding the completion of the proposed transactions. Forward-looking statements address future events and conditions and are necessarily based upon a number of estimates and assumptions. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as "expects" or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "estimates" or "intends", or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved), and variations of such words, and similar expressions are not statements of historical fact and may be forward-looking statements. Forward-looking statement are necessarily based upon several factors that, if untrue, could cause the actual results, performances or achievements of the Company to be materially different from future results, performances or achievements express or implied by such statements. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including the price of gold and other metals, anticipated costs and the ability to achieve goals, and the Company will be able to obtain required licenses and permits. While such estimates and assumptions are considered reasonable by the management of the Company, they are inherently subject to significant business, economic, competitive and regulatory uncertainties and risks including that resource exploration and development is a speculative business; that environmental laws and regulations may become more onerous; that the Company may not be able to raise additional funds when necessary; fluctuating prices of metals; the possibility that future exploration, development or mining results will not be consistent with the Company's expectations; operating hazards and risks; and competition. There can be no assurance that economic resources will be discovered or developed. Accordingly, actual results may differ materially from those currently anticipated in such statements. Factors that could cause actual results to differ materially from those in forward looking statements include continued availability of capital and financing and general economic, market or business conditions, the loss of key directors, employees, advisors or consultants, equipment failures, litigation, competition, fees charged by service providers and failure of counterparties to perform their contractual obligations. Investors are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. The forward-looking statements included in this news release are made as of the date hereof and the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities legislation.

 

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

 

New Destiny Mining Corp. (TSXV: NED) is a featured mining stock on Investorideas.com

 

More info on NED at Investorideas.com Visit: https://www.investorideas.com/CO/NED/  

 

Disclaimer/Disclosure: New Destiny Mining Corp. (NED.V) is a paid featured mining stock on Investor Ideas. More info:Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact management and IR of each company directly regarding specific questions. More disclaimer and disclosure info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

 

 

Get more mining stock investor ideas- news, articles, and podcasts and stock directories

 

Breaking Medical Technology News: Aethlon Medical (NASDAQ: $AEMD) Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

 

Breaking Medical Technology News: Aethlon Medical (NASDAQ: $AEMD) Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

 

Results Support Future Study of the Hemopurifier® as Part of a Machine Perfusion Circuit to Further Assess its Association with Function of Retrieved Kidneys

 

SAN DIEGO, CA - August 27, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the publication in preprint of an in vitro study in bioRxiv on August 24, 2024, entitled, "The Hemopurifier® Removes Extracellular Vesicles and microRNAs From Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys."

 

Aethlon Medical's Hemopurifier® is a therapeutic blood filtration system designed to bind and remove harmful exosomes and life-threatening viruses from blood and other biological fluids, qualities which have potential applications in oncology and infectious diseases, as well as in the organ transplant setting.

 

This news is paid advertisement/ news disseminated on behalf of/issued on behalf of Aethlon Medical Inc.

 

Read this news, featuring AEMD in full at https://www.investorideas.com/news/2024/08271AEMD-Hemopurifier-Preclinical-data.asp

"Kidney transplantation provides the highest quality of life for those afflicted with end stage renal disease, yet a significant shortage in the number of donor kidneys currently exists," stated Steven LaRosa, MD, Senior Author of the paper and Chief Medical Officer of Aethlon Medical. "To bridge the gap between recipients and donors, the criteria for the use of kidneys from deceased brain death and diseased circulatory death donors has been extended. However, kidneys from extended criteria donors are associated with higher rates of poor graft function and acute rejection in recipients. The release of extracellular vesicles (EVs) and microRNAs from the donor kidney are hypothesized to play a role in these complications and are targets for the, Hemopurifier®."

 

Given that one approach to lessen these complications and potentially increase the time of assessment of organ viability is to use machine perfusion on recovered kidneys, and, based on Aethlon Medical's prior data in COVID-19 and oncology, it was hypothesized that the Hemopurifier® could remove EVs and microRNAs from renal perfusates. In this proof-of-concept study, the company obtained four perfusates from discarded donor kidneys that had undergone a type of machine perfusion called Controlled Oxygenated Rewarming (COR). These perfusates were then pumped over the Hemopurifier® and analyzed for EV counts and microRNA levels. The results confirmed the removal of both small and larger size EVs and a significant reduction in microRNAs.

 

"While our primary focus is to conduct our planned clinical trials of the Hemopurifier® in India and Australia, in patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy, the data generated by this proof-of-concept study is encouraging and provides evidence for adding the transplant indication to our product pipeline," added James Frakes, Interim Chief Executive Officer and Chief Financial Officer of Aethlon Medical. "Next steps to consider would be an additional pre-clinical study comparing mediator removal, renal function and histopathology in a machine perfusion circuit performed both with and without incorporation of the Hemopurifier® on discarded kidneys.

Ultimately, a clinical trial designed to demonstrate that incorporation of the Hemopurifier® into renal perfusion improves important clinical endpoints in transplant recipients such as delayed graft function, graft survival or rejection rates would likely be required."

 

About Aethlon and the Hemopurifier®

Aethlon Medical is a medical therapeutic company focused on developing the Hemopurifier, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. In human studies, the Hemopurifier has demonstrated the removal of life-threatening viruses and in pre-clinical studies, the Hemopurifier has demonstrated the removal of harmful exosomes from biological fluids, utilizing its proprietary lectin-based technology. This action has potential applications in cancer, where exosomes may promote immune suppression and metastasis, and in life-threatening infectious diseases. The Hemopurifier is a U.S. Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption (IDE) application related to the treatment of life-threatening viruses that are not addressed with approved therapies.

 

Additional information can be found at www.AethlonMedical.com.

 

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that involve risks and uncertainties. Statements containing words such as "may," "believe," "anticipate," "expect," "intend," "plan," "project," "will," "projections," "estimate," "potentially" or similar expressions constitute forward-looking statements. Such forward-looking statements are subject to significant risks and uncertainties and actual results may differ materially from the results anticipated in the forward-looking statements. These forward-looking statements are based upon Aethlon's current expectations and involve assumptions that may never materialize or may prove to be incorrect. Factors that may contribute to such differences include, without limitation, the Company's ability to raise additional capital and to successfully complete development of the Hemopurifier; the Company's ability to successfully demonstrate the utility of the Hemopurifier in cancer and infectious diseases and in the transplant setting; the Company's ability to achieve and realize the anticipated benefits from potential milestones; the Company's ability to submit applications to and obtain approval from the additional Ethics Committees in Australia and India, including on the timing expected by the Company; the Company's ability to initiate its planned oncology clinical trials in Australia and India, including on the timing expected by the Company; the Company's ability to manage and successfully complete its clinical trials, if initiated; the potential impact of Hemopurifier on the H5N1 Avian Influenza (H5N1 HPAI) virus in dairy cattle; the Company's ability to successfully manufacture the Hemopurifier in sufficient quantities for its clinical trials, and other potential risks. The foregoing list of risks and uncertainties is illustrative, but is not exhaustive. Additional factors that could cause results to differ materially from those anticipated in forward-looking statements can be found under the caption "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended March 31, 2024, and in the Company's other filings with the Securities and Exchange Commission, including its quarterly Reports on Form 10-Q. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except as may be required by law, the Company does not intend, nor does it undertake any duty, to update this information to reflect future events or circumstances.

 

Company Contact:
Jim Frakes
Interim Chief Executive Officer and Chief Financial Officer
Aethlon Medical, Inc.
Jfrakes@aethlonmedical.com

 

Investor Contact:
Susan Noonan
S.A. Noonan Communications, LLC
susan@sanoonan.com
917-513-5303

 

SOURCE Aethlon Medical, Inc.

 

Aethlon Medical Inc. (Nasdaq:AEMD) is a featured biotech stock on Investorideas.com

 

More info on AEMD at Investorideas.com Visit: https://www.investorideas.com/CO/AEMD/

 

Get News Alerts on Aethlon Medical

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: Aethlon Medical, Inc. (NASDAQ:AEMD) is a paid featured stock on Investorideas.com More disclaimer info:  https://www.investorideas.com/About/News/Clientspecifics.asp  https://www.investorideas.com/About/Disclaimer.asp

Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

 

Biotech Industry Stocks- investing ideas in biotechnology stocks, medical technology and life sciences

Get more biotech and medical tech news, articles, podcasts and stock directories

 

Junior Copper Miner from Down Under CopperCorp Resources Inc. (TSXV: CPER) (OTCQB: CPCPF), Gains on Project Updates

 

Junior Copper Miner from Down Under CopperCorp Resources Inc. (TSXV: CPER) (OTCQB: CPCPF), Gains on Project Updates

Investorideas.com (www.investorideas.com) a go-to platform for big investing ideas, including mining stocks reports on trading for  junior miner, CopperCorp Resources Inc. (TSXV: CPER) (OTCQB: CPCPF), focused on the exploration and development of its Skyline and AMC copper-gold-REE Projects in western Tasmania.

The stock made the TSXV top percentage gainer list on news, currently trading at 0.0800, up 0.0350, gaining 77.7778% for investors. The stock has traded over 1/7 Million shares as of this report.

Today the company provided an update on its 100% owned Razorback Copper-Gold-REE property in western Tasmania, Australia.

Highlights

New 3D inversion modelling of magnetic and gravity data indicates highly prospective coincident magnetic pipe and gravity features at the Jukes and Hydes target zones characteristic of IOCG deposits and with similarities to the Mt Lyell Cu-Au system (3Mt contained copper at 1% Cu, and 3Moz contained gold at 0.3g/t Au) located along trend immediately to the north.

The position of these magnetic and gravity features directly adjacent to large fertile fault structures, and outcropping magnetite and copper-gold mineralization in both areas is considered highly prospective.

Drilling access track construction scheduled to commence at Jukes during late August.

 

Stephen Swatton, President and CEO of CopperCorp commented:

 

"This is 'game changing' news in terms of our understanding of the potential of the entire Razorback property. The regional geophysical interpretation that the team have been working on with consultants clearly shows strong analogies between our Razorback license with the world class Mt Lyell copper district 20km along strike to the north.

 

The spring / summer fieldwork season has just commenced in Tasmania and the Company plans to release regular updates of the progress. We will also be releasing details of our anticipated copper-gold drill program at Jukes soon with the expectation that with further refining of the geophysics and integration of Jukes data, drill targets at Hydes will be announced before year end. The permission for drilling at Jukes is already confirmed and we anticipate future drill permits will again be issued in a matter of weeks rather than months upon application due to the current pro-resource sentiment at the Tasmanian State level."

 

Jukes and Hydes Zones - Large Scale Magnetitic-Gravity Targets

 

New data processing and 3D inversion modelling of magnetic and gravity data shows vertically extensive pipe-like magnetic features with coincident to off-set residual gravity anomalies at both the Jukes and Hydes target zone areas. The position of these magnetic and gravity features directly adjacent to large NW-trending faults in both areas is considered highly prospective for structurally controlled mineralized pipes typical of the Mt Lyell system where anomalous gravity features occur associated with the larger mineralized pipe bodies that have depth extensive chlorite-magnetite-apatite-biotite alteration zones (e.g. Prince Lyell and Western Tharsis orebodies - Figure 3).

 

As previously reported for the Jukes Zone1, results of 3D inversion modelling show an elongate pipe-like magnetic high feature with the core of the pipe extending up to 700m in a N-S direction, and up to 1.4km vertically below outcropping mineralization at surface (Figures 4 and 6). The magnetic high is coincident with magnetite bearing Cu-Au mineralization and an enveloping zone of k-feldspar-magnetite-pyrite alteration sampled at surface1. Results from recent channel sampling of underground historical workings at Jukes, including 31.0m @ 1.48% Cu and 0.83g/t Au1, confirmed high-grade copper-gold potential at the prospect. Results of 3D gravity inversion modelling has defined a significant gravity high anomaly located adjacent and partially overlapping the modelled magnetic pipe at Jukes. The gravity anomaly is slightly NW-SE elongated over a distance of 1km with average amplitudes between 2.5 to 3.5mGal with a peak of 3.9mGal. The area of the modelled gravity high feature is overlain by cover sequence rocks and has not been tested by previous exploration.

 

At the Hydes target zone, a modelled elongated magnetic pipe feature extends up to 1km vertically and occurs directly adjacent to and overlapping a circular residual gravity high anomaly around 1km in diameter with a peak amplitude of 4.6mGal, positioned on a large NW-trending fault structure (Figures 5 and 6). Historical sampling (BHP - 1960's) of outcropping chalcopyrite mineralized chloritic schists flanking the modelled magnetitic feature at Hydes returned 23.0m @ 0.8% Cu (gold not assayed, see figure 4.). A second and larger gravity anomaly occurs along the same structural trend approximately 2km to the NW of the magnetic-gravity pair anomaly at Hydes. This second anomaly is elongated E-W over a distance of 2.4km and has a peak magnitude of 7.1mGal. The Hydes target zone area remains untested by drilling.

Recent news:

https://ca.finance.yahoo.com/news/coppercorp-confirms-further-large-scale-110000608.html

Research more mining stocks with Investorideas.com free stock directory

https://www.investorideas.com/Gold_Stocks/Stocks_List.asp

Check out the Exploring Mining Podcast at Investorideas to hear great thought leaders

https://www.investorideas.com/Audio/Podcasts-Exploring-Mining.asp

  

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for sectors including mining, crypto, renewable energy, gaming, biotech, tech, sports and more. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: More disclaimer and disclosure info https://www.investorideas.com/About/Disclaimer.asp  Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Learn more about digital advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on X @investorideas @stocknewsbites

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

Contact Investorideas.com

800 665 0411

 

New Tech, Retail, Automotive, Biotech & Homebuilder Stocks; (OTCQX: $NORSF) (Nasdaq: $PAYC)(CSE: $CLDV.CN)(TSX: $IFA.TO) (OTCQX: $WPNTF)(NASDAQ: $VFS)(TSX: $KSI.TO)(NYSE: $LPX)

New Tech, Retail, Automotive, Biotech & Homebuilder Stocks; (OTCQX: $NORSF) (Nasdaq: $PAYC)(CSE: $CLDV.CN)(TSX: $IFA.TO) (OTCQX: $WPNTF)(NASDAQ: $VFS)(TSX: $KSI.TO)(NYSE: $LPX)

 

 

 

 

August 23, 2024 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch in the Tech, Retail, Automotive, Biotech & Homebuilder sectors.  

 

The newest tech companies include a public investment platform focused on disruptive tech, a payroll software provider and a metal 3D printing company.

 

The latest retail companies are an apparel and a cosmetics company, respectively while the newest automotive company is an EV (electric vehicle) manufacturer.

 

The latest biotech company provides a digital validation platform and the newest homebuilder company is a high-performance building solutions provider.

 

Read this in full at https://www.investorideas.com/news/2024/main/08231Stocks.asp

 

Investor Ideas is always on the hunt for new stocks to add to our growing list of free stock directories. The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector. 

 

New Stocks Added to the Tech Directories:

Norsk Titanium AS (OTCQX: NORSF; Oslo: NTIS) is a global leader in metal 3D printing, innovating the future of metal manufacturing by enabling a paradigm shift to a clean and sustainable manufacturing process. With its proprietary Rapid Plasma Deposition® (RPD®) technology and 700 MT of production capacity, Norsk Titanium offers cost-efficient 3D printing of value-added metal parts to a large addressable market. RPD® technology uses significantly less raw material, energy, and time than traditional energy-intensive forming methods, presenting customers with an opportunity to better manage input costs, logistics, and environmental impact. RPD® printed parts are already flying on commercial aircraft, and Norsk Titanium has gained significant traction with large defense and industrial customers

 

Paycom Software, Inc. (Nasdaq:PAYC) For 25 years, Paycom Software, Inc. (NYSE: PAYC) has simplified businesses and the lives of their employees through easy-to-use HR and payroll technology to empower transparency through direct access to their data. And thanks to its industry-first solution, Beti®, employees now do their own payroll and are guided to find and fix costly errors before payroll submission. From onboarding and benefits enrollment to talent management and more, Paycom’s software streamlines processes, drives efficiencies and gives employees power over their own HR information, all in a single app. Recognized nationally for its technology and workplace culture, Paycom can now serve businesses of all sizes in the U.S. and internationally.

 

Cloud3 Ventures Inc. (CSE:CLDV) formerly Orthogonal Global Group Inc -  is a global accelerator, and public investment platform focused on accelerating and investing in the top companies and projects in disruptive industries. Cloud3 provides access to these groundbreaking companies and private projects in a public investment vehicle with liquidity and transparency. The Issuer believes that it is in the Orthogonal intersection of wellness, healthcare, AI, tokenization, deep tech and fintech spaces that will move humanity towards a more utopian society.

 

New Stocks Added to the Retail Directories:

iFabric Corp. (OTCQX: IFABF; TSX: IFA) two strategic divisions offer a variety of products and services through wholly-owned subsidiaries, namely, Intelligent Fabric Technologies (North America) Inc. ("IFTNA") and Coconut Grove Pads Inc. ("Coconut Grove").

IFTNA is focused on development and sale of high-performance sports apparel, medical protective apparel, consumer protective apparel, and proprietary treatments that provide "intelligent" properties to fabrics, foams, plastics, and numerous other surfaces, thereby improving the safety and well-being of the user. Such intelligent properties include antiviral and antibacterial characteristics, water-repellence and UV protection, among others.

Coconut Grove, operating as Coconut Grove Intimates, is a designer, manufacturer, distributor, licensor and licensee of ladies' intimate apparel products and accessories.

 

Warpaint London PLC (OTCQX: WPNTF; LSE: W7L) sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to major retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, Warpaint supplies cosmetics under its other brand names of Man'stuff, Body Collection and Chit Chat, each targeting a different demographic.

 

New Stocks Added to the Automotive/Transportation Directories:

VinFast Auto Ltd. (NASDAQ: VFS) a subsidiary of Vingroup JSC, one of Vietnam's largest conglomerates, is a pure-play electric vehicle ("EV") manufacturer with the mission of making EVs accessible to everyone. VinFast's product lineup today includes a wide range of electric SUVs, e-scooters, and e-buses. VinFast is currently embarking on its next growth phase through rapid expansion of its distribution and dealership network globally and increasing its manufacturing capacities with a focus on key markets across North America, Europe and Asia.

 

New Stocks Added to the Biotech Directories:

kneat.com, Inc. (OTCQX: KSIOF; TSX: KSI) enable regulated organizations to move from paper-based validation to intelligent, digitized, paperless solutions. And we do it through the ongoing development of a powerful, purpose-built software platform. In 2014, after 8 years of intensive software development, we launched the world’s most advanced validation software to help revolutionize the speed, precision, transparency and intelligence of validation in the Life Sciences sector. The solution is now used by some of the world’s leading Life Sciences companies.

 

New Stocks Added to the Homebuilder Directories:

Louisiana Pacific Corp (NYSE: LPX) As a leader in high-performance building solutions, Louisiana-Pacific Corporation (LP Building Solutions, NYSE: LPX) manufactures engineered wood products that meet the demands of builders, remodelers and homeowners worldwide. LP’s extensive portfolio of innovative and dependable products includes Siding Solutions (LP® SmartSide® Trim & Siding, LP® SmartSide® ExpertFinish® Trim & Siding, LP BuilderSeries® Lap Siding and LP® Outdoor Building Solutions™), LP® Structural Solutions (LP® TechShield® Radiant Barrier, LP WeatherLogic® Air & Water Barrier, LP Legacy® Premium Sub-Flooring, LP® FlameBlock® Fire-Rated Sheathing, LP NovaCore® Thermal Insulated Sheathing and LP® TopNotch® 350 Durable Sub-Flooring) and oriented strand board (OSB). In addition to product solutions, LP provides industry-leading customer service and warranties. Since its founding in 1972, LP has been Building a Better World™ by helping customers construct beautiful, durable homes while shareholders build lasting value. Headquartered in Nashville, Tennessee, LP operates 22 plants across the U.S., Canada, Chile and Brazil.

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for various sectors, including gaming, biotech, tech and sports. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter (X)  https://X.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com to be added to our stock directories or learn more about us

Dawn Van Zant and Cali Van Zant

 

800 665 0411